Patents by Inventor Masahiro Yutani

Masahiro Yutani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Adjuvant for mucosal vaccine
    Patent number: 10226529
    Abstract: An object of the present invention is to provide an adjuvant for a mucosal vaccine with high safety that induces a sufficient immune response in a mucosal membrane. According to the present invention, an adjuvant for a mucosal vaccine containing a protein complex composed of hemagglutinin (HA) subcomponents HA1 and HA2, and mutant subcomponent HA3 of botulinum toxin is provided.
    Type: Grant
    Filed: June 2, 2015
    Date of Patent: March 12, 2019
    Assignee: Osaka University
    Inventors: Nao Jonai, Yukako Fujinaga, Masahiro Yutani, Yo Sugawara, Takuhiro Matsumura
  • ADJUVANT FOR MUCOSAL VACCINE
    Publication number: 20170196970
    Abstract: An object of the present invention is to provide an adjuvant for a mucosal vaccine with high safety that induces a sufficient immune response in a mucosal membrane. According to the present invention, an adjuvant for a mucosal vaccine containing a protein complex composed of hemagglutinin (HA) subcomponents HA1 and HA2, and mutant subcomponent HA3 of botulinum toxin is provided.
    Type: Application
    Filed: June 2, 2015
    Publication date: July 13, 2017
    Applicant: OSAKA UNIVERSITY
    Inventors: Nao Jonai, Yukako Fujinaga, Masahiro Yutani, Yo Sugawara, Takuhiro Matsumura
  • Adjuvant for mucosal vaccine
    Patent number: 9662386
    Abstract: An object of the present invention is to provide an adjuvant for a mucosal vaccine with high safety that induces a sufficient immune response on the mucosa. According to the present invention, an adjuvant for a mucosal vaccine comprising a protein complex composed of hemagglutinin (HA) subcomponents HA1, HA2, and HA3 of botulinum toxin is provided.
    Type: Grant
    Filed: July 29, 2016
    Date of Patent: May 30, 2017
    Assignee: Osaka University
    Inventors: Yukako Fujinaga, Takuhiro Matsumura, Masahiro Yutani, Nao Jonai
  • ADJUVANT FOR MUCOSAL VACCINE
    Publication number: 20160324960
    Abstract: An object of the present invention is to provide an adjuvant for a mucosal vaccine with high safety that induces a sufficient immune response on the mucosa. According to the present invention, an adjuvant for a mucosal vaccine comprising a protein complex composed of hemagglutinin (HA) subcomponents HA1, HA2, and HA3 of botulinum toxin is provided.
    Type: Application
    Filed: July 29, 2016
    Publication date: November 10, 2016
    Applicants: DAIICHI SANKYO COMPANY, LIMITED, OSAKA UNIVERSITY
    Inventors: Yukako Fujinaga, Takuhiro Matsumura, Masahiro Yutani, Nao Jonai
  • ADJUVANT FOR MUCOSAL VACCINE
    Publication number: 20150306214
    Abstract: An object of the present invention is to provide an adjuvant for a mucosal vaccine with high safety that induces a sufficient immune response on the mucosa. According to the present invention, an adjuvant for a mucosal vaccine comprising a protein complex composed of hemagglutinin (HA) subcomponents HA1, HA2, and HA3 of botulinum toxin is provided.
    Type: Application
    Filed: November 15, 2013
    Publication date: October 29, 2015
    Applicants: DAIICHI SANKYO COMPANY LIMITED, OSAKA UNIVERSITY
    Inventors: Yukako Fujinaga, Takuhiro Matsumura, Masahiro Yutani, Nao Jonai